We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.
Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence
Heide Jackson , Kara Mandell , Kimberly Johnson , Debanjana Chatterjee , David J. Vanness
Substance Abuse
Vol. 36, Iss. 2, 2015
This study assesses the cost-effectiveness of XR-NTX for the treatment of opioid dependence. We find that public payors may be interested in adopting XR-NTX if they are willing to pay an additional $72 dollars per patient per day beyond treating patients with methadone maintenance treatment. The cost-effectiveness analysis is one component that may guide policy decisions; other factors like patient preferences and the effectiveness of treatment for other comorbid conditions may help determine the best course of treatment for particular subgroups.